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ABSTRACT
Only few selected cancer cells drive tumor progres-
sion and are responsible fortherapy resistance. Their
specific genomic characteristics, however, are
largely unknown because high-resolution genome
analysisiscurrently limitedtoDNApooledfrommany
cells. Here, we describe a protocol for array com-
parative genomic hybridization (array CGH), which
enables the detection of DNA copy number changes
in single cells. Combining a PCR-based whole
genome amplification method with arrays of highly
purified BAC clones we could accurately determine
known chromosomal changes such as trisomy 21 in
single leukocytes as well as complex genomic imbal-
ances of single cell line cells. In single T47D cells
aberrant regions as small as 1–2Mb were identified in
most cases when compared to non-amplified DNA
from 10
6 cells. Most importantly, in single micro-
metastatic cancer cellsisolatedfrombone marrowof
breast cancer patients, we retrieved and confirmed
amplifications as small as 4.4 and 5Mb. Thus, high-
resolution genome analysis of single metastatic
precursor cells is now possible and may be used for
the identification of novel therapy target genes.
INTRODUCTION
The concept of a hierarchical organization of solid cancers
holds that only few selected cancer cells—possibly cancer
stem cells—give rise to local relapses and distant metas-
tases and are responsible for therapy resistance. Interest-
ingly, the presence of single disseminated cancer cells in
bone marrow of breast cancer patients without manifest
metastasis confers a high risk for later occurring metastatic
relapse (1). These extremely rare cells seem to comprise the
metastatic precursor cells. In breast cancer patients, genetic
analysis using single cell metaphase CGH revealed that
they disseminate very early during genomic progression of
the disease (2) and diﬀer from their matched primary
tumors (3). Therefore the genetic analysis of primary
tumors is apparently unsuited to detect changes that are
selected during metastatic dissemination. Since identiﬁca-
tion of such changes may lead to novel therapy target
genes, direct high-resolution analysis of the metastatic
precursor cells seems to be mandatory.
Recently, resolution for the detection of DNA copy
number changes could be increased by array CGH about
100-fold for DNA from pooled cells (4). Reliable mea-
surements of sub-megabase single-copy number imbal-
ances have been reported for amounts of 1–500ng of
high-quality DNA (4,5). However, application of array
CGH to single cells was only possible when the data were
smoothed over large regions, a procedure that resulted in a
resolution equivalent to metaphase CGH (6,7). We had
previously developed a protocol suited for metaphase
CGH for whole genome ampliﬁcation of single cell DNA
and for analysis of loss of heterozygosity (2,8). We there-
fore investigated whether a protocol could be established
that allows hybridization of ampliﬁed single cell DNA to
CGH arrays achieving similar genomic resolution as
for pooled DNA. Hybridization to existing BAC- and
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zation to speciﬁcally designed BAC-arrays and identiﬁed
preparation of the microarray and the quality of the single
cell sample as critically important.
MATERIALS AND METHODS
Constructionof 3KBAC array
BAC isolation. The FISH-mapped BAC clone library
(FISH Mapped Clones V1.3) was purchased from
BACPAC Resources Center (http://bacpac.chori.org/).
All BAC-clones were subjected to T7-end-sequencing, the
end-sequences were BLASTed against the human genome
and annotation was corrected if necessary. In total 11.2%
of the BAC-clones were not annotated correctly, out of
those 3% were localized on chromosomes diﬀerent from
the ones indicated.
Bacteria were grown in LB medium containing 20mg/ml
chloramphenicol. Standard preparation of BAC DNA was
performed by using Qiagen midi columns (Qiagen, Hilden,
Germany) according to the manufacturer’s recommenda-
tions. For preparation of BAC DNA by pulsed-ﬁeld gel
electrophoresis, bacterial agarose-inserts were prepared as
described with minor modiﬁcations (9) and digested with
PI-SceI. Brieﬂy, the bacteria were pelleted by centrifuga-
tion, embedded in 1% low-melt agarose and lysed with
lysozyme and RNAse (over night incubation at 378C with
6mM Tris-HCl pH 7.5, 1M NaCl, 100mM EDTA, 0.5%
Brij-58, 0.2% deoxycholate, 0.5% lauryl sarcosine,
30U/ml RNase (DNase free), 50000U/ml lysozym)
followed by proteinase K digestion of the cellular proteins
(overnight incubation at 508C with 0.5M EDTA pH 9.0,
1% lauroyl-sarcosine, 1.5U/ml proteinase K). Fragmented
DNA was removed by gel-electrophoresis at 4V/cm for 2h
in 0.5 TAE buﬀer. The BAC DNA was digested with
PI-SceI for 3h at 378C after allowing the enzyme to diﬀuse
into the agarose-insert by overnight incubation on ice
(1.5U/100ml PI-SceI; 100mM KCl; 10mM Tris-HCl pH
8.6; 10mM MgCl2; 1mM dithiothreitol; 3.5mg BSA).
Subsequently, the proteinase K digest was repeated.
After inactivation of proteinase K by auto-hydrolysis,
the agarose-inserts were equilibrated in TE, loaded on a
1% low-melt agarose gel, and the DNA was separated
by PFGE in 0.5 TAE using settings recommended by
the manufacturer (Amersham Bioscience). The BAC DNA
was gel-extracted by an overnight agarase digest (1U
agarase per 100ml gel-volume in 30mM Bis-Tris pH 4.5;
10mM EDTA) and precipitated with isopropanol and
Na-acetate (3M) at 48C. After washing with 70% ethanol,
the DNA was resuspended in 10ml TE.
Amplification of isolated DNA. All BAC DNA prepara-
tions were ampliﬁed by the adapter-linker method (8,10)
with minor modiﬁcations and by DOP-PCR as described
(11). To avoid cross-hybridization with the adaptors
from the single cell PCR products, we selected diﬀerent
sequences for the adaptors that were ligated to BAC DNA,
i.e. 50-CTGTGTCTGACGACTCAGTCT-30 and 50-TAA
GACTGAGTCdd-30. Phi29 ampliﬁcations were per-
formed with the TempliPhi Kit (Amersham Biosciences)
according to manufacturer’s recommendations.
Preparation of BAC microarray. BAC probes were
ethanol precipitated after PCR or strand displacement
ampliﬁcation. For the test array, comprising 30 BAC
clones derived from the FISH-mapped clones of the V1.3
library (for clone names and localization see Supplemen-
tary Table 1), DNA concentration was adjusted to
0.4mg/mli n3  SSC. Probes were printed in replicas of
ﬁve on amino-silane coated slides (Corning, GAPS II)
using an Omnigrid 100 spotting robot (Genomic Solutions,
Ann Arbor, USA). DNA was immobilized by UV cross-
linking followed by 30min baking at 808C.
For the 3K array DNA concentration was adjusted to
0.8mg/ml in water and complemented with 2 sciSPOT
spotting-buﬀer (Scienion, Berlin) to a ﬁnal concentration
of 0.4mg/ml. The slides were printed in replicas of two and
post-processed by Scienion AG, Berlin, Germany, using
the sciPROCESS buﬀer. For this, slides were washed in
558C sciPROCESS buﬀer for 15min, then washed once in
distilled water for 5min at 558C and twice in distilled
water for 25min at 258C. Then the slides were dried by
centrifugation at 900rpm. Spot quality was assessed after
staining with Sybr Green.
Labeling of sampleDNA
Adapter-linker ampliﬁed test and reference DNA were
labeled by PCR in presence of Cy5 or Cy3 conjugated
nucleotides, respectively. For all single cell array CGH
experiments the same male reference DNA was used,
which was generated from 1000 cells after MseI digest and
ampliﬁcation. The 100ml PCR mix comprised 13mM
Tris-HCl pH 9.5, 3.25mM MgCl2,5mM LIB1 primer (10),
200mM dATP and dGTP, 180mM dTTP and dCTP,
20mM Cy3/Cy5-dUTP (Amersham Biosciences) and
Cy3/5-dCTP (Amersham Biosciences), 16 U Thermo
Sequenase (Amersham Biosciences), 0.8ml template
DNA. The MJ-research thermocycler was programmed
to 9 cycles of 948C 1min, 608C 30s, ramp to 728C with
0.28C/s, 728C 5min with 60s extension/cycle.
Non-ampliﬁed genomic DNA from T47D cell line and
leukocytes of healthy donors and a patient with trisomy 21
were prepared with Wizard Genomic DNA Puriﬁcation
Kit (Promega) according to the manufacturer´s recom-
mendations. Labeling of pooled genomic DNA and
human placental reference DNA was performed according
to Snijders et al. (12) using the BioPrime DNA labeling
system (Invitrogen). Unincorporated nucleotides were
removed by a Sephadex G50 column. For hybridization
of the 19K array two vials of labeled DNA were pooled.
Hybridization of the3K BAC array
Eluted labeled DNA was precipitated together with 80mg
C0t-1-DNA (Roche) and resolved in 45ml mastermix (50%
formamide, 2 SSC, 4% SDS and 0.08g/ml dextrane
(MW>500000; Fisher Biotech). The samples were allowed
to resolve for 1h at 428C, were then denatured at 758C for
10min and incubated for 2h at 428C to allow blocking of
repetitive sequences. Hybridization was performed with-
out cover slip at 428C in a humidiﬁed chamber for two
nights on a shaker as described (13) for the test array. The
3K array was hybridized with coverslip for 24h in
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pausing ratio of 3:7. Before hybridization of target DNA,
the array was pre-hybridized overnight at 428C with 80ml
mastermix as above, containing 250mg herring sperm
DNA and 100mg mock control DNA (adapter-linker PCR
product, ampliﬁed without addition of cellular DNA).
Following hybridization, slides were washed 10min in
1 PBS/0.05% Tween at room temperature, 30min in
2 SSC/50% formamide at 428C and 10min in 1 PBS/
0.05% Tween (all pH 7.4) at room temperature and ﬁnally
dried by centrifugation.
Analysis ofarray data
Arrays were scanned with an Axon 4000A scanner (Axon
Instruments, Union City, USA). GenePix Pro V4.0
software (Axon Instruments, Union City, USA) was
used to locate features automatically and to measure
ﬂuorescence intensities for Cy3 and Cy5 channels.
Data analysis of the 30 BAC clone test array was
performed according to Quackenbush (14). Brieﬂy, the
geometric means of the BAC clone replicas were
calculated and the ﬂuorescence signal intensities of the
Cy3 and Cy5 channel were globally normalized. BAC
clones in chromosomal areas aﬀected by copy number
losses or gains were excluded when the signal intensity was
normalized. For all BAC clones, the ratio of the normal-
ized ﬂuorescence intensity was log2-transformed and
plotted against the chromosomal location. Copy number
diﬀerences were assumed to be signiﬁcant, if the signal
intensity ratios of the aﬀected BAC clones exceeded the
upper or lower thresholds deﬁned by the three-times
standard deviation that was calculated from the baseline
noise. The 3K array data were analyzed using the
CAPweb software (http://bioinfo-out.curie.fr/CAPweb/)
(15) and visualized using VAMP (16). Only features with
reference ﬂuorescence intensity at least two-fold over the
background were included in the analysis. For all other
parameters, default values of the software were used
(except for the settings of MANOR.nk which were
adapted to the size of the array). For visualization of the
data normalized, log2-transformed ﬂuorescence ratios are
plotted against genomic location. All shown hybridization
proﬁles are displayed in the ‘gained/lost color code’
modus. The breakpoint detection and status assignment
of genomic regions is performed by the GLAD package
(http://bioinfo-out.curie.fr/CAPweb/), for which default
parameters recommended in the manual were used for
analysis. Outliers are deﬁned as unreliable spots by the
software, for their detection the risk factor a is set to
0.001. Data points whose log2 ratios are within upper or
lower a/2-region of the normal distribution are deﬁned as
outliers and are not taken into account for the assignment
of normal/gained/loss-status to a region. Fourteen BAC-
clones were detected as outliers in 40% of analyzed
hybridization proﬁles and were thus excluded from
analysis.
Single-cellPCR,metaphaseCGHandsequence-specificPCR
Single cell adapter-linker PCR and metaphase CGH were
performed as published (3,8,10).
To assess quality of DNA samples from global genome
ampliﬁcation of single cells, the DNA was subjected to
PCR for ﬁve diﬀerent markers. Markers were chosen such
that they were localized on large MseI-fragments, ranging
from 1034 to 1936bp. PCR was conducted as previously
described by Schardt et al. (2), template DNA was diluted
1:50 in nuclease-free water. Primer sequences are available
upon request.
Quantitative PCR
Quantitative PCR was performed using the LightCycler
System (Roche, Mannheim, Germany) and the
LightCycler FastStart DNA Master SYBR Green I kit
(Roche) according to the manufacturer’s recommenda-
tion. The forward and reverse primer sequences for the
ampliﬁcation of E. coli TRPE genomic sequence and the
pBACe3.6 vector sequence were taken from Foreman
et al. (17), without the additional probe beacon (primer
sequences are provided in Supplementary Table 2). The
LightCycler Relative Quantiﬁcation Software (Roche) was
used to evaluate the runs. PCR eﬃciency normalization
and a reference sample were included for every run. The
total amount of vector and E. coli DNA in the samples
was calculated in an exponential equation with the
ampliﬁcation eﬃcacy of the vector or E. coli PCR
reactions (1.92 and 1.93 respectively) as base to the
power of the crossing points for each sample pair. The
ratio of vector versus E. coli DNA was determined and
expressed as percentage of contaminating E. coli DNA in
the samples.
For the analysis of the gains on chromosomes 12p and
14q in single cells (Figure 5), three primer pairs were
selected within the AKAP3 locus (chromosome 12) and
three primer pairs within the AKAP6 locus (chromosome
14; indicated by asterisks in Figure 5A and B). Three
primer pairs within balanced regions (SMS2 locus on
chromosome 4 and BC and IL-6 locus on chromosome 7;
indicated by arrows in Figure 5A and B) served as
controls. Measurements were performed in duplicates.
Primer sequences are provided in Supplementary Table 2.
Ten normal single cells were used for statistical compar-
ison. The relative quantiﬁcation was performed as
described in Schardt et al. (2). Brieﬂy, to assess the
normal relative ratios of the regions we tested all six loci in
ten single control cells together with the two tumor cells
and an additional micrometastatic cell of the same patient
and performed a rank-sum test for statistical diﬀerences.
To estimate the copy numbers of the AKAP3 and AKAP6
genes the normalized ratios of target and reference genes
of the tumor cells were divided by the normalized ratios of
target and reference genes of the control cells.
Statistical analysis
Correlations between array CGH and metaphase CGH
experiments and between array CGH hybridization
proﬁles were calculated by bivariate correlation analysis
using a two-tailed Spearman-Rho test. Statistical diﬀer-
ence between qPCR values of the analyzed tumor cells and
control cells was determined by applying a two-tailed
Mann–Whitney non-parametric test.
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RESULTS
Contamination withbacterial DNA impedes arrayCGH
ofsingle cells
We ﬁrst tested arrays that had been successfully used to
analyze large amounts of DNA from primary tumors (20)
and hybridized DNA ampliﬁed from single cells of known
karyotypes onto these arrays. Unfortunately, we were
unable to correctly determine the chromosome copy
numbers of the test samples (data not shown). As
underlying reason we found that contaminating bacterial
DNA is introduced during single cell sample preparation
with enzymes that are needed for the ampliﬁcation of
cellular DNA (proteinase K, MseI, T4 DNA ligase and
Taq polymerase). This contamination after PCR ampliﬁ-
cation depends on the ratio of the starting cellular target
DNA to contaminating DNA, i.e. it increases with lower
cell numbers (Figure 1A). The bacterial nature of this
contamination was veriﬁed by sequencing (e.g. E. coli
sequences L-asparagine transporter, tryptophane synthase
subunit B, transcriptional repressor of hyc and NAD
synthetase were identiﬁed). We hypothesized that bacterial
or plasmid DNA contaminating our single cell prepara-
tions hybridizes to bacterial or plasmid DNA present on
the BAC array which then causes large signal ﬂuctuations.
To test this hypothesis we hybridized labeled mock control
samples that had been prepared without the addition of
human DNA. Indeed, no signals were detected on
metaphase spreads while the intensely ﬂuorescent hybrid-
ization pattern on BAC arrays could hardly be distin-
guished from samples containing DNA ampliﬁed from
human cells (data not shown). These pilot experiments
revealed that in single cell experiments contaminating
bacterial DNA has an even greater inﬂuence on hybridiza-
tion outcome than previously recognized in standard
experiments (21).
Purification of BACDNA, array preparationand
hybridization conditions
Consequently, we tested whether BAC array platforms
free of contaminating DNA enable array CGH of single
cells. Thus, we had to establish BAC preparation
essentially free of contaminating non-human DNA, to
avoid hybridization of labeled non-human DNA in the
sample to homologous sequences on the array. We tested
various approaches, including long-range PCR, in vitro
transcription of the BAC inserts, subtractive enrichment
of the BAC DNA, and the puriﬁcation of the BAC clones
by pulsed ﬁeld gel electrophoresis (PFGE) (9). The latter
proved to be superior to all other strategies, because it
enabled both highest recovery and best puriﬁcation of the
BAC DNA. The RP11-BAC clones used for this purpose
contain a recognition site of the homing endonuclease
PI-SceI in the pBACe3.6 backbone sequence, which is
neither present in the E. coli genome nor in mammalian
genomes (22). Indeed, selective linearization of the RP11-
BAC clones enabled the physical separation from the
circular E. coli genomic DNA during PFGE (Figure 1B),
whereas circular BACs could not be separated under the
applied conditions. The puriﬁcation of the BAC DNA
from E. coli DNA was veriﬁed by quantitative PCR
Figure 1. Contamination of ampliﬁed DNA samples and PFGE
puriﬁcation of BAC DNA from E. coli DNA. (A) Ampliﬁed DNA
from empty-control for the ampliﬁcation PCR, 1 cell, 100 cells and
40000 cells (from left to right) were spotted onto a membrane and
hybridized with Dig-labeled bacterial contamination. The more human
cellular DNA was added, the weaker the hybridization signal of the
labeled contamination. The PCR-mock-control contains the highest
amount of contamination. (B) Schematic illustration of the pulsed-ﬁeld-
gel-electrophoresis (PFGE) of PI-SceI digested RP11-BAC clones.
A PI-SceI site is located in the pBACe3.6 vector sequence, while no
restriction site is present in the genomic DNA of E. coli. The linearized
BAC DNA is recovered after gel-electrophoresis by gel extraction
(BAC clones 86c20, 106m3). (C) and (D) E. coli contamination of BAC
clone preparations determined by qPCR before and after adapter-
linker-ampliﬁcation, respectively. The same 15 BAC clones were
prepared by PFGE- and conventional puriﬁcation. The contamination
with E. coli DNA is expressed as percentage of TRPE sequence in
comparison to pBACe3.6 sequence.
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While we detected only traces of contaminating E. coli
DNA in PFGE-puriﬁed samples (0.32% 0.11 SD), BAC
clones conventionally prepared using Qiagen columns
were contaminated to a varying degree (1.3–25.2%,
average 8.0% 6.0 SD) (Figure 1C), the average purity
of these column-puriﬁed BAC preparations being similar
to reported data (6–10%) (17). Also, after ampliﬁcation of
the isolated BAC-DNA, the contamination of column-
puriﬁed BAC-DNA was substantially higher as compared
to PFGE-puriﬁed BACs (Figure 1D).
The DNA from 30 RP11 clones, isolated by both PFGE
and conventional columns, was used for the generation of
a test array. The two BAC DNA preparations were
ampliﬁed using adapter-linker-PCR, DOP-PCR and
Phi29 rolling-circle-ampliﬁcation, methods which have
been previously described for array preparation after
conventional BAC preparation (4,12,21,23). The resulting
six diﬀerent DNA samples obtained from each RP11 clone
were spotted together onto one glass slide (ﬁve replicas
each) for a direct comparison of hybridization results.
We ﬁrst hybridized 500ng of non-ampliﬁed DNA
extracted from peripheral blood cells of a patient with
trisomy 21 to the test array. All BAC clones from
chromosome 21 displayed the expected copy number
gain regardless which preparation and ampliﬁcation
method was used (Figure 2A–F), verifying the suitability
of both PFGE and conventional BAC DNA isolation
methods for this application. However, when DNA from a
single leukocyte of the same patient was ampliﬁed by
adapter-linker PCR (8) and subsequently hybridized onto
the diﬀerently prepared BAC clone sets (Figure 2G–L;
color switch experiments), the trisomy 21 was only
detected by PFGE puriﬁed clones (Figure 2G–I) but not
by column-puriﬁed clones (Figure 2J–L). Array CGH with
DNA from single leukocytes of healthy donors (n=3)
showed normal ratios for all BAC clones (data not
shown). Of the three methods for BAC DNA ampliﬁca-
tion adaptor-linker PCR was superior to DOP-PCR and
Phi29-ampliﬁcation (Figure 2G and M), because it showed
the lowest values for false-positive and false-negative
signals (Figure 2M). This is possibly due to perfectly
matching DNA fragments when probe and target are
generated by MseI digest.
Genome-wide arrayCGHof single cells
With these results in hand we puriﬁed 2940 FISH-mapped
BAC clones by PFGE and generated an array with an
average resolution of 1Mb. For the validation of this 3K
BAC-array we performed experiments with DNA from
samples with known karyotypes to determine hybridiza-
tion performance. First, log2 ratios for balanced BAC
clones were found to be  0.01 0.15 for non-ampliﬁed
DNA (n=4) and  0.02 0.22 for ampliﬁed single-cell
DNA (n=5). Second, repeated hybridization of identical
samples from pooled DNA (n=3) and single-cell samples
(n=3) resulted in correlation coeﬃcients of 0.91 0.06,
and 0.84 0.1, respectively. Suitability of the single
cell samples for array CGH analysis was assessed by
performing a PCR for 5 markers localized on long
MseI-fragments with sizes of >1000bp (data not
shown). Samples were used for labeling and hybridization
when at least 4 of the 5 markers could be detected.
Next, we hybridized single leukocytes from healthy
male (data not shown) and female donors (Figure 3A),
and from a male patient with trisomy 21 (Figure 3B)
against a male reference DNA which was generated from
1000 cells after MseI digest and ampliﬁcation. The male–
male proﬁle displayed balanced clones throughout the
genome, the female–male proﬁle showed normal auto-
somal clones and a relative loss of chromosome Y and
gain of chromosome X. In the single cell DNA sample of
the patient with trisomy 21, the gain of chromosome 21
was detected readily.
However, chromosome 19 was reproducibly deleted in
all analyzed single cell hybridizations. As potential reason
we identiﬁed the GC-content of BAC clones which was
signiﬁcantly higher in BAC clones of chromosome 19 as
compared to chromosome 3 clones (Figure 3C). BAC
clones with high GC-content—the critical threshold being
about 45% GC-content—were erroneously assigned as
deleted. Removing all BAC clones with GC-content above
45% resulted in a correct classiﬁcation of chromosome 19
(Figure 3D and E). After correction for chromosome 19,
the mean false positive rate of all BAC clones was 0.09%.
False-negative assignments, i.e. on chromosome 21 for
trisomy 21 cells and gonosomes in mismatch experiments,
were never observed.
Resolution of 3KBAC arrayand comparison with
oligonucleotide arrays
We next analyzed complex genomic imbalances in cancer
genomes. Since the hallmark of epithelial cancers is
chromosomal instability, we searched for a cell line,
which displays little inter-laboratory variation of complex
genomic rearrangements, and harbors most rearrange-
ments in most of the individual cells. Of the cell lines
tested by metaphase CGH (CAMA, CAL51, MCF-7,
SKBR3, T47D; data not shown), T47D was the one to
meet both criteria best. In addition, T47D had been
previously analyzed on a 3K (12) and on a high-resolution
32K BAC array (24) and we expected these data to serve
as useful independent reference. Therefore, we hybridized
non-ampliﬁed DNA from pooled T47D cells and two
single-cell samples on our 3K BAC array. In a direct
comparison, the identical samples were hybridized on two
commercially available oligonucleotide arrays comprising
244K (Agilent) and 19K (Operon) oligonucleotides. All
samples were identically labeled but were hybridized using
optimized conditions for each platform. Samples for the
3K BAC array and 19K array were hybridized in our lab,
samples for the 244K array by the manufacturer. No
selection of BAC clones or oligonucleotides, e.g. according
to GC-content, was performed in any evaluation.
The data obtained from pooled DNA samples proved
that all hybridizations worked well, revealing extensive
congruency among the diﬀerent platforms as well as to
proﬁles of the T47D cell line that were previously
published. All hybridizations, including the single cell
samples were therefore compared with the proﬁle from
PAGE 5 OF 10 Nucleic Acids Research, 2008, Vol. 36, No. 7 e39Figure 2. Hybridization of the test-array using DNA from pooled cells and ampliﬁed single cell DNA from a patient with trisomy 21. The six
diﬀerent BAC DNA preparations were spotted onto one array and hybridized with Cy3- and Cy5-labeled reference and test DNA probes. The log2
transformed ratios of test-to-reference DNA ﬂuorescence intensities are plotted against the chromosomal locations of the BAC clones. Dashed gray
and black/blue lines represent the base line and the upper/lower signiﬁcance thresholds deﬁned by the three-times standard deviation, respectively.
(A–F) Non-ampliﬁed DNA from 10
6 cells (G–L) Ampliﬁed single cell DNA. Note that the trisomy 21 is only detected by the PFGE-ampliﬁed BAC-
clones (G–I). Red dots represent the experiment in which probe and reference were labeled with Cy5 and Cy3, respectively, the green dots represent
the color switch experiment and ‘+’ represents the mean log2 ratio of both experiments. The 3-fold standard deviation is calculated individually from
the balanced clones in each experiment and as threshold the average standard deviation is shown (blue line). (A–C) and (G–I): PFGE puriﬁcation of
BAC clones; (D–F) and (J–L) Qiagen preparation of BAC clones. (A, D, G, J): adapter-linker PCR; (B, E, H, K): DOP-PCR; (C, F, I, L): Phi29
rolling circle ampliﬁcation. (M) Statistical evaluation of results from diﬀerent BAC-preparations. Averages from three independent experiments are
shown. (Mse: Adaptor-linker-PCR; STDEV: standard deviation).
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directly all platforms by referencing regions of gain and
losses to the array with the highest density of features.
Thus, we identiﬁed normal, gained or deleted regions of
diﬀerent sizes in the reference sample, then determined the
BAC clones mapping in these regions, and assessed the
percentage of BAC clones that correctly recalled the status
of the reference. In all analyses (see Supplementary text
and ﬁgures), we found that the 3K BAC array out-
performed the oligonucleotide arrays. In particular,
detection of small gains and losses (1–20 Mb) was
impossible using oligonucleotide arrays (Figure 4). In
contrast, on the 3K BAC array both single cells displayed
mostly congruent results with the pooled DNA even for
gains and losses as small as 1 Mb (Figure 4 and
Supplementary Figure 6). Here, 60.5 5.2% of gains,
losses and interspersed normal regions smaller than 20Mb
were assigned as in the reference DNA. Aberrations and
normal regions larger than 20Mb were concordant for
reference and test sample in 77.6 14.7%.
Oligonucleotide arrays could rarely retrieve gains and
losses and artiﬁcially assigned most aberrant regions as
being balanced (Figure 4). Identical assignment of small
gains, losses and interspersed normal regions to reference
was observed for 19K and 244K arrays in 40.1 28.3%
and 33.9 45.7%, respectively, and for larger regions
(>20–200 Mb) in 42.8 35.4% and 36.4 45.2%.
Array CGHof micrometastatic breastcancer cells
Finally, we hybridized individually processed micrometa-
static cancer cells that had been isolated from the bone
marrow of breast cancer patients (Figure 5 and data not
shown). Comparison with metaphase CGH data con-
ﬁrmed the measurements on the array (mean correlation
coeﬃcient 0.92 0.02). However, array CGH identiﬁed
genomic changes that previously escaped detection by
metaphase CGH. For example, while on chromosome 11
the loss of the p-arm is readily detected by both methods,
the apparent gain of chromosomal material of
chromosome 11q does not become signiﬁcant in meta-
phase CGH. As uncovered by array CGH this is caused by
two small deleted regions of 7Mb and 0.5Mb within an
ampliﬁed locus—present in both cancer cells—which
apparently decreased the averaged signal intensity in
metaphase CGH (Figure 5C). Array CGH was able to
pinpoint gains on chromosomes 12p and 14q with sizes of
4.4 and 5Mb, respectively (Figure 5A–C). To validate
these ampliﬁcations, we applied a previously developed
quantitative PCR assay for genomic DNA isolated from
single cells (2). Three primer pairs were chosen from each
of the ampliﬁed regions, comprising the AKAP3-locus on
12p and AKAP6 on 14q (indicated by asterisks in
Figure 5A–C). Copy numbers were quantiﬁed by compar-
ing qPCR values obtained for primers amplifying the
AKAP 3 and 6 genes to three control loci (BC and IL-6 on
chromosome 7 and SMS2 on chromosome 4; indicated by
arrows in Figure 5A and B), which displayed no
aberrations. The qPCR assay conﬁrmed the gain of the
AKAP3 and AKAP6 sequences for all three analyzed
tumor cells (P=0.001 for AKAP3 and P<0.001 for
AKAP6 for each cell) and indicated that the amplicons
were present in 4 to 7 copies (Figure 5D).
DISCUSSION
Here we provide a protocol for BAC array CGH of single
cells that enabled the detection of copy number changes at
high resolution. This was achieved by combining our
adaptor-linker PCR ampliﬁcation protocol for single cells
(8) with a novel BAC array using PFGE-puriﬁed DNA.
This array is essentially free of contaminating bacterial
DNA, which was key to success. Experiments using single
cells with known karyotypes, such as single normal cells
and single cells from patients with trisomy 21, served to
test the newly developed 3K BAC array and yielded the
expected results. Complex genotypes of single T47D cells
were correctly retrieved using the 3K BAC array and
proﬁles were concordant with proﬁles of non-ampliﬁed
Figure 3. Performance of 3K BAC array. (A) and (B) Hybridization of ampliﬁed single cell-DNA from a female healthy donor and a patient with
trisomy 21, respectively, to 3K BAC array versus male reference DNA. The log2-transformed ﬂuorescence intensity ratios are plotted against the
chromosomal locations of the BAC clones. Gray color of dots indicates normal clones, green indicates loss and red indicates gain of chromosomal
material. Blue indicates high-copy ampliﬁcation. Outliers are marked by a box around the data point; (data normalization and visualization were
performed with CAPweb software). (C) GC-content (%) of BAC clones from chromosomes 3 (light gray) and 19 (dark gray) (n=30 clones were
analyzed for both chromosomes). (D) and (E) Details of chromosomes 3 and 19 from panels A and B after selection of chromosome 19 BAC clones
with GC-content <45% (n=6).
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T47D-proﬁles (24). Comparison of the 3K BAC array
with commercially available 19–244K oligonucleotide
arrays revealed, ﬁrst, that a data point of the 3K BAC
array is much more reliable than a data point of an
oligonucleotide array; second, that a density of 244000
oligonucleotides is insuﬃcient to perform as good as our
3K BAC array and third, that single cell analysis on
oligonucleotide arrays without knowing the outcome is
currently not possible. It remains to be tested in the future
whether larger oligonucleotide arrays will enable single
cell array CGH analysis.
Although array CGH for single cells has been published
previously (6,7,25), the advancement by our approach is
underscored by the fact that even a BAC array with 10
times as many BAC clones as ours still did not exceed the
resolution of metaphase CGH (6). In contrast, the 3K
BAC array reliably detected gains as small as 4.4 and
5 Mb in single disseminated tumor cells, which were
subsequently conﬁrmed by an independent method. This
ﬁnding is in line with the observation that gains, deletions
and interspersed balanced regions of pooled T47D cells
ranging from 1 to 20 Mb were also found in T47D single
cells in 60.5 5.2%, including nine regions smaller than 2
Mb. In contrast to the 3K BAC array, both oligonucleo-
tide arrays were generally unable to correctly assign small
and large regions of gains and losses. Since we also
observed genomic divergence between pooled T47D cells
and the individual cells upon metaphase CGH, some of
the gains and losses diverging between reference and single
cell samples will be true diﬀerences. Therefore, the correct
identiﬁcation of small and large gains or losses by the 3K
BAC array in a single cell is certainly higher than 60% and
77%, respectively.
We obtained ﬁrst evidence that the performance of
our single cell BAC array can be further improved. For
example, we already noted that some BAC clones on
chromosome 19 led to assignment of incorrect deletions.
Adjustment for GC-content of chromosome 19 BAC
clones was an adequate remedy. Thus, some BAC clones
may not be suited for single cell array CGH and a
careful bioinformatic evaluation might uncover rules for
Figure 4. Comparison of the 3K BAC array and the 19K and 244K oligonucleotide arrays. (A) Hybridization proﬁles of chromosome 10 from
hybridization with T47D cell line DNA. From left to right: Hybridization proﬁle of 10
6 T47D cells to a 32K BAC array taken from Shadeo et al.,
hybridization of T47D DNA ampliﬁed from two individual single cells on the 3K BAC array, the 19K and 244K oligonucleotide arrays. In all
proﬁles, the blue line represents the hybridization proﬁle of 10
6 T47D cells on the 244K oligonucleotide array as a reference. The red line represents
the single cell proﬁles on the various platforms. Log2 ratios are plotted against chromosomal location of data points. The vertical lines in the proﬁles
indicate the threshold of signiﬁcant deviations from normal ( 0.2). (B–D) Percentage of correctly detected ampliﬁcations, deletions and normal
regions in T47D single cell proﬁles on the three diﬀerent platforms. Regions between 1 and 20Mb detected in single cell 1 (B) and single cell 2 (C).
Regions between >20 and 200Mb are provided as an average of single cell 1 and 2 (D).
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version of our BAC array already enabled the ﬁrst high-
resolution analysis of single micrometastatic cells isolated
from bone marrow of breast cancer patients. While
the overall proﬁles correlated signiﬁcantly with their
metaphase CGH proﬁles, additional changes could be
retrieved. These had apparently been selected during
cancer progression or were at least expanded within the
disseminated tumor cell population as they were found in
independently isolated cancer cells from one patient.
The concordant results underscore the reliability of the
method, as does the quantitative PCR assay for the
ampliﬁed regions.
The novel array CGH protocol may be suited for
numerous additional applications. Examples include the
study of minute amounts of ex vivo DNA from prema-
lignant lesions or very small tumors, or from biopsies
before and after systemic therapy. Single cell resolution
will also allow addressing questions that could not be
asked before. In the current discussion about cancer stem
cells the degree of genetic instability can now be assessed
in stem cells and transiently amplifying cells to uncover
the origin of numerical DNA aberrations. Likewise,
genomic causes underlying human ageing (26,27) are
thought to be stochastic in nature and notoriously escape
when pooled DNA is analyzed. Therefore, array CGH of
Figure 5. Hybridization of two adapter-linker ampliﬁed DNA samples from disseminated tumor cells isolated from bone marrow of a breast cancer
patient. The metaphase CGH proﬁle of each sample is plotted beneath the array CGH proﬁle. Chromosome ideograms are placed horizontally to
position the corresponding genomic regions of metaphase and array CGH next to each other for direct comparison. (A) Single tumor cell 1, (B)
single tumor cell 2, (C) gain of resolution by array CGH. Two small inserted deletions on the q-arm of chromosome 11 (7Mb and 500kb in size;
from centromer to telomer) and the high-copy ampliﬁcations on chromosomes 12p (4.4Mb) and 14q (5Mb) are present in both single cells. Colour
code and axes as in Figure 3. Arrows and asterisks point to primer binding sites used as controls or target regions, respectively, for qPCR. (D)
Calculated copy numbers of AKAP3 and 6 in single disseminated tumor cell 1, 2 and 3 as calculated from qPCR results (assuming a diploid genome).
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biological and medical questions.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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